BridgeBio Pharma (BBIO) PT Raised to $91 at BTIG
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $79.89 +0.04%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
BTIG analyst Thomas Shrader raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $91.00 (from $49.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- York Space Systems (YSS) PT Lowered to $15 at Jefferies
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
